Gentamicin Once-Daily (q24h) Dosing
For most adults with normal renal function, gentamicin should be dosed at 5-7 mg/kg IV once daily, NOT the traditional 3 mg/kg/day divided dosing, when used for serious gram-negative infections outside of endocarditis. However, the context matters critically—endocarditis requires divided dosing.
Critical Context-Dependent Dosing
For Endocarditis (Enterococcal or Staphylococcal)
Do NOT use once-daily dosing. The American Heart Association guidelines explicitly state that gentamicin should be given in divided doses (2-3 times daily) for endocarditis 1:
- Adults: 3 mg/kg/24h divided into 2-3 doses (typically 1 mg/kg q8h)
- Target levels: Peak 3-4 mcg/mL, trough <1 mcg/mL
- Rationale: Animal models show conflicting results for once-daily dosing in endocarditis, and the pharmacokinetics differ from other infections 1
For Other Serious Infections (Non-Endocarditis)
Once-daily dosing is appropriate and preferred 2:
- Adults with normal renal function:
- Serious infections: 3 mg/kg q24h
- Life-threatening infections: 5 mg/kg q24h (reduce to 3 mg/kg when clinically stable)
- Target peak: 4-6 mcg/mL (avoid prolonged levels >12 mcg/mL)
- Target trough: <2 mcg/mL
Pediatric Dosing
Children 2:
- 6-7.5 mg/kg/day divided q8h (2-2.5 mg/kg q8h)
Infants and neonates 2:
- 7.5 mg/kg/day divided q8h (2.5 mg/kg q8h)
Premature/full-term neonates ≤1 week 2:
- 5 mg/kg/day divided q12h (2.5 mg/kg q12h)
Recent evidence suggests higher doses may be needed in neonates to achieve therapeutic peaks 3:
- 3.5 mg/kg achieved therapeutic peaks in 98% vs. only 77-87% with 2.5 mg/kg
- Dosing intervals: q36h if <30 weeks GA, q24h if ≥30 weeks GA
Renal Impairment Adjustments
The dose interval must be extended, not the dose reduced 2, 4:
| Creatinine Clearance | Recommended Interval |
|---|---|
| ≥60 mL/min | q24h |
| 40-59 mL/min | q36h |
| 20-39 mL/min | q48h |
| <20 mL/min | Consult ID specialist |
Practical calculation: Interval (hours) = Serum creatinine (mg/dL) × 8 2
For patients on hemodialysis: Give 1-1.7 mg/kg after each dialysis session (approximately 50% removed during 8-hour dialysis) 2.
Monitoring Requirements
Therapeutic drug monitoring is essential 2:
Peak levels (30-60 min after IM or 1h after IV infusion):
- Target: 4-6 mcg/mL for standard dosing
- For once-daily high-dose: 8-10 mcg/mL acceptable
- Avoid prolonged levels >12 mcg/mL
Trough levels (just before next dose):
- Target: <1 mcg/mL (endocarditis)
- Target: <2 mcg/mL (other infections)
Frequency: Measure periodically during therapy, especially if:
Important Caveats
Dosing Based on Lean Body Mass
Always calculate dose using lean body weight in obese patients, not actual body weight 2. Gentamicin distributes in extracellular fluid, not adipose tissue.
Age-Related Considerations
- Elderly/underweight patients: May need dose reduction and closer monitoring 5
- Young patients with high body weight: May need dose increase 5
- Children show age-dependent pharmacokinetics: Younger children (0.5-5 years) require 2.5 mg/kg per dose vs. 1.5 mg/kg for those >10 years to achieve similar peaks 6
Duration of Therapy
- Standard: 7-10 days 2
- If >10 days: Monitor renal, auditory, and vestibular function closely (toxicity risk increases) 2
- Short courses (≤3 days): May not require trough monitoring in patients with normal renal function 5
Nephrotoxicity Risk
Extended interval dosing shows approximately 4% nephrotoxicity rate, with 1% irreversible 4. Risk increases with:
- Concomitant nephrotoxic drugs (NSAIDs, vancomycin)
- Prolonged therapy
- Inadequate trough monitoring
- Pre-existing renal impairment